Neuroendocrine neoplasms (NENs) can be difficult to detect, and many patients face long delays before receiving an accurate diagnosis. In many cases, NENs are not found until they have advanced or spread. Detecting NENs earlier could change that trajectory. When disease is found sooner, surgery may offer the best chance for long-term control and, in some cases, a cure.
To accelerate progress, NETRF has launched its first research funding opportunity focused specifically on early detection. The 2026 Early Detection Request for Applications will support research aimed at finding NENs earlier, identifying precursor or early-stage lesions, and detecting recurrence or progression in people at elevated risk or in defined clinical settings. Priority areas include biomarker tests, imaging approaches, risk prediction tools, and digital or longitudinal monitoring strategies.
Researchers interested in applying must submit letters of intent by June 15, 2026, at 5 PM ET. Selected applicants will be invited to submit full applications. Both letters of intent and invited full applications must be submitted through ProposalCentral. Researchers can review the full guidelines for eligibility, scope, and application instructions, and questions may be directed to grants@netrf.org.